Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 EPS of $0.23, $0.48 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $9.02 million versus the consensus estimate of $8.14 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.